Related Experiment Video
Updated: Aug 1, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Inhaled volatile anesthetic gas for severe bronchospasm in the emergency department
Osman Adi1, Farah Nuradhwa Apoo1, Chan Pei Fong1
1Resuscitation & Emergency Critical Care Unit (RECCU), Trauma & Emergency Department, Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia.
Abstract:
Bronchospasm is caused by reversible constriction of the smooth muscles of the bronchial tree. This causes obstruction of the lower airways, which is commonly seen at the emergency department (ED) in patients with acute exacerbation of asthma or chronic obstructive pulmonary disease. Ventilation may be difficult in mechanically intubated patients with severe bronchospasm due to airflow limitation, air trapping, and high airway resistance. The beneficial effects of volatile inhaled anesthetic gas had been reported due to its bronchodilation properties. In this case series, we would like to share our experience delivering inhaled volatile anesthetic gas via a conserving device for three patients with refractory bronchospasm at the ED. Inhaled anesthetic gas is safe, feasible and should be considered as an alternative rescue therapy for ventilated patients with severe lower airway obstruction.
More Related Videos
Related Concept Videos
Inhalational Anesthetics: Overview
Cardiopulmonary Resuscitation II: ACLS Airway Management
Parenteral Anesthetics: Overview
Inhaled Medications
Skeletal Muscle Relaxants: Therapeutic Uses
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

